Last reviewed · How we verify

NCT06329726

Long-Term Behavioral and Cognitive Outcomes of Deep Brain Stimulation in Patients With Parkinson's Disease

Recruiting now Last updated 26 March 2024
What this trial tests

trial testing Clinical examinations and clinical scales administration in Parkinson Disease in 52 participants. Currently enrolling.

Timeline
13 December 2021
Primary endpoint
15 December 2031
15 December 2032

Quick facts

Lead sponsorFondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
StatusRecruiting now
Study typeOBSERVATIONAL
Enrollment52
Start date13 December 2021
Primary completion15 December 2031
Estimated completion15 December 2032
Sites1 location across Italy

Drugs / interventions tested

Conditions studied

Sponsor

Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico

Who can join

Adults 18 to 70, any sex, with Parkinson Disease. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this observational study is to evaluate the long-term effect of DBS-STN on cognitive and behavioral outcomes in Parkinson's disease (PD) patients. PD patients will be assessed over time using tests, questionnaires and standardized clinical scales. An initial assessment (T0) and annual follow-up assessments will be carried out for 5 years. Researchers will compare data collected from patients with DBS versus patients with best medical therapy.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Triple perspective: assessing deep brain stimulation outcomes in Parkinson's disease.
    Mellace D, Mameli F, Ruggiero F, Cogiamanian F, et al · · 2025 · PMID 41088049 · DOI 10.1186/s12883-025-04455-3

Verify or expand the search:

Other trials of Clinical examinations and clinical scales administration

Trials testing the same drug.

Other recruiting trials for Parkinson Disease

Currently open trials in the same condition.

Other Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06329726.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing